Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Moskowitz, Craig H Nademanee, Auayporn Masszi, Tamas Agura, Edward Holowiecki, Jerzy Abidi, Muneer H Chen, Andy I Stiff, Patrick Gianni, Alessandro M Carella, Angelo Osmanov, Dzhelil Bachanova, Veronika Sweetenham, John Sureda, Anna Huebner, Dirk Sievers, Eric L Chi, Andy Larsen, Emily K Hunder, Naomi N Walewski, Jan